Get started
Author

Maria Cavaller-Bellaubi

Observed names: Cavaller Bellaubi, Maria, M. Cavaller-Bellaubi, Maria Cavaller, Maria Cavaller Bellaubi, Maria Cavaller-Belaubi
ORCID: 0000-0002-6658-6863
Observed ORCID: 0000-0002-6658-6863
OpenAlex ID: A5025784505
Drug repurposing for rare: progress and opportunities for the rare disease community
2024 · Anneliene Hechtelt Jonker, Daniel O’Connor, et al. · Frontiers in Medicine · 67
PDF
Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action
2021 · Maria Cavaller-Bellaubi, Stuart D. Faulkner, et al. · Therapeutic Innovation & Regulatory Science · 61
PDF
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents
2022 · Nicholas M Croft, Lissy de Ridder, et al. · Journal of Crohn s and Colitis · 45
PDF
The European Medicines Agency facilitates access to medicines in low- and middle-income countries
2020 · Maria Cavaller Bellaubi, Martin Harvey Allchurch, et al. · Expert Review of Clinical Pharmacology · 27
PDF
Dental anomaly pattern (DAP): Agenesis of mandibular second premolar, distal angulation of its antimere and delayed tooth formation
2013 · Joana Navarro, Maria Cavaller, et al. · The Angle Orthodontist · 20
PDF
Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years’ multi-stakeholder dialogue on improving access in Europe via MoCA
2023 · Maria Cavaller-Bellaubi, Wills Hughes-Wilson, et al. · Orphanet Journal of Rare Diseases · 13
PDF
Framing the European Rare Diseases field through a structured movement of patient organisations
2024 · Maria Cavaller-Bellaubi, Virginie Hivert, et al. · Rare Disease and Orphan Drugs Journal · 8
Access in the rare diseases landscape
2024 · Anneliene H Jonker, Maria Cavaller-Bellaubi, et al. · The Lancet Global Health · 5
A multi-stakeholder perspective on medical devices for children and adolescents with type 1 diabetes: huge unmet needs for the smallest
2025 · Torben Biester, Felix Reschke, et al. · Journal of Pediatric Endocrinology and Metabolism · 2
A matrix tool to foster patient engagement in children, adolescents and young adults: report from a multistakeholder workshop
2024 · Maria Cavaller-Bellaubi, Eva Degraeuwe, et al. · Research Involvement and Engagement · 2
PDF
SATURN: assessing the feasibility of utilising existing registries for real-world evidence data collection to meet patients, regulatory, health technology assessment and payer requirements
2024 · L. Sangiorgi, M. Boarini, et al. · Orphanet Journal of Rare Diseases · 2
PDF
Parents' and children's needs in the drug development process
2024 · Maria Cavaller-Bellaubi, Ariane Weinman, et al. · Elsevier eBooks · 2
Engaging families with experience of neonatal hypoxic ischemic encephalopathy: a call to action
2026 · Betsy Pilon, Maria Cavaller-Bellaubi, et al. · Pediatric Research · 1
PDF
A roadmap for therapeutic innovation in paediatric chronic kidney disease
2026 · Mandy Wan, Rukshana Shroff, et al. · Nature Reviews Nephrology
Engaging children, adolescents and young adults living with rare diseases as research partners: practical considerations for meaningful involvement
2026 · Maria Cavaller-Belaubi, Elena-Alexandra Tataru, et al. · Frontiers in Pediatrics
PDF
Timing and rate of reimbursement for cystic fibrosis modulator therapies in EU countries
2026 · Enrico Costa, Silvia Girotti, et al. · Journal of Cystic Fibrosis
Contributors
2024 · Moji Adeyeye, Sammy Ainsworth, et al. · Elsevier eBooks
Oc 8431 Clinical Research and Sustainable Development in Sub-saharan Africa: the Impact of North-south Partnerships
2019 · Agnes Saint-Raymond, Martin Harvey, et al. · BMJ Global Health
PDF
Facilitating Access to Medicines in Low- and Middle-Income Countries: Role of EMA?
2019 · Agnes Saint-Raymond, Maria Cavaller Bellaubi, et al. · SSRN Electronic Journal
Works count: 21
Citation count: 255
H-index: 7
I10-index: 6
Year
Topic
Type